The multipronged organization has a lab space on the working waterfront and an academy, the Gloucester Biotechnology Academy, ...
U.S. News compares companies to their industry peers based on a variety of company fundamentals, performance metrics and investor preferences to help you find the right stocks for your investing style ...
The Petroleum Technology Development Fund (PTDF) has commenced interviews for 5,885 candidates shortlisted from over 38,000 applicants for its 2026/2027 Overseas Scholarship Scheme (OSS). Speaking ...
Climb Bio on Tuesday said there are currently no FDA-approved treatments for pMN, which affects about 75,000 people in the U.S. and can lead to chronic or end-stage kidney disease, requiring dialysis ...
A burgeoning field is launching its first clinical trial to find out whether dialling back cell development can safely ...
Among product types, D-galactose is expected to dominate the market with a 72.0% share in 2025. Its widespread use in ...
Renovare Therapeutics, Inc., a privately-held biotechnology company pioneering regenerative therapeutics for osteoarthritis, today announced its formal launch from stealth mode and collaboration with ...
Revolutionary DNA test by BillionToOne could transform early cancer detection and prenatal screening in the US.
Another Cambridge biotech is entering the arena, this one with $100 million in venture capital financing and a plan to create ...
Danaher has increased its dividend for 13 consecutive years, and its dividend growth has been nothing short of spectacular.
As the Trump administration cracks down on the H-1B visa program, which allows skilled workers like software engineers to ...
By David Levin April 3, 2026 A founding father of microbiome research is honored for discoveries that have transformed our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results